Hard to say what the outlook truly is, but at least at 12 weeks Ampion showed significance.
Saline is an active therapy, and a useful one for inflammation, both in joint and prolotherapy.
I remain hopeful.
As just a trading thought- I see these levels as a gift. Any future trial initiation gets us moving to .50+ again, and hopefully $1-2 as trial progresses. With that mindset, I’m still a buyer.